SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0000950157-10-001880
Filing Date
2010-09-28
Accepted
2010-09-28 15:43:42
Documents
6
Effectiveness Date
2010-09-28

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 s8-pos.htm S-8 POS 114173
2 2006 EQUITY INCENTIVE PLAN ex4-1.htm EX-4.1 181291
3 AMENDMENT 2010-1 TO THE 2006 EQUITY INCENTIVE PLAN ex4-2.htm EX-4.2 9184
4 2003 EQUITY INCENTIVE PLAN ex4-3.htm EX-4.3 187320
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-2.htm EX-23.2 6413
6 signature.jpg GRAPHIC 3079
  Complete submission text file 0000950157-10-001880.txt   504493
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-168254 | Film No.: 101093724
SIC: 2834 Pharmaceutical Preparations